Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Intensity Therapeutics Inc. (INTS) had Non-Operating Income/Expense of $0.08M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.01M |
|
-- |
|
-- |
|
$3.08M |
|
$-3.08M |
|
|
Non-Operating Income/Expense |
$0.08M |
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.01M |
|
$-3.08M |
|
$-3.08M |
|
2.71M |
|
2.71M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$11.23M |
|
-- |
|
$0.29M |
|
$11.52M |
|
$2.25M |
|
$0.06M |
|
$0.06M |
|
$2.31M |
|
$9.21M |
|
$9.21M |
|
$9.21M |
|
2.95M |
|
| Cash Flow Statement Financials | |
$-4.17M |
|
-- |
|
$1.77M |
|
$11.92M |
|
$9.53M |
|
$-2.39M |
|
$0.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.00 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-32.64% |
|
-32.64% |
|
-26.10% |
|
-32.42% |
|
$3.13 |
|
$-1.54 |
|
$-1.54 |
|